摘要
1问题:影响华法林抗凝效果的因素有哪些?
回答:由于房颤患者发生缺血性脑卒中危险性是无房颤者的5倍,其病死率增加2倍,故在房颤治疗中抗凝治疗防止血栓栓塞事件发生十分重要。研究表明华法林抗凝治疗可使脑卒中的发生率减少2/3,病死率下降1/3,而用阿司匹林预防血栓栓塞发生疗效仅为华法林的1/2。
出处
《中国医刊》
CAS
2011年第9期89-90,共2页
Chinese Journal of Medicine
同被引文献15
-
1Murphy N F,Simpson C R,Jhund P S,et al.A national survey of the prevalence,incidence,primary care burden and treatment of atrial fibrillation in Scotland[J].Heart,2007,93(5):606-612.
-
2Fuster V,Rydén L E,Cannom D S,et al.ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Revise the 2001guidelines for the management of patients with atrial fibrillation)developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J].Europace,2006,8(9):651-745.
-
3Frost L,Engholm G,Johnsen S,et al.Incident stroke after discharge from the hosp ital with a diagnosis of atrial fibrillation[J].Am J Med,2000,108(1):36-40.
-
4Pisters R,Lane D A,Nieuwlaat R,et al.A novel userfriendly score(HAS-BLED)to assess 1-year risk of major bleeding in patients with atrial fibrillation:the Euro Heart Survey[J].Chest,2010,138(5):1093-1100.
-
5Camm A J,Lip G Y,De Caterina R,et al.2012focused update of the ESC Guidelines for the management of atrial fibrillation:an update of the 2010 ESC Guidelines for the mana gement of atrial fibrillation developed with the special contribution of the European HeartRhythm Association[J].Europace,2012,14(10):1385-1413.
-
6ACTIVE Investigatiors,Connolly S J,Pogue J,et al.Effect of clopidogrel added to aspirin in patients with atrial fibrillation[J].N Engl J Med,2009,360(20):2066-2078.
-
7Sato H,Ishikawa K,Kitabatake A,et al.Lowdose aspirin for prevention of stroke in low-risk patients with atrial fibrillation:Japan Atrial Fibrillation Stroke Trial[J].Stroke,2006,37(2):447-451.
-
8Olesen J B,Lip G Y,Lindhardsen J,et al.Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation:A net clinical benefit analysis using a'real world'nationwide cohort study[J].Thromb Haemost,2011,106(4):739-749.
-
9JCS Joint Working Group.Guidelines for pharmacotherapy of atrial fibrillation(JCS2008):digest version[J].Circ J,2010,74(11):2479-2500.
-
10Liu B,Liu L Z,Xuan J,et al.Treatment patterns associated with storke prevention in patients with atrial fibrillation in three major cities in the People's Republic of China[J].Int J Gen Med,2013,7:29-35.
二级引证文献5
-
1刘芳,余飞,叶露.小剂量利伐沙班与法华林在高龄心房颤动患者抗凝及安全性中的对比研究[J].湖南师范大学学报(医学版),2021,18(5):275-278. 被引量:4
-
2蔡萍.干预川崎病并发冠状动脉损害的用药护理研究[J].中国城乡企业卫生,2020,35(7):96-98. 被引量:1
-
3薛桐,蒋志敬,隋坤鹏,王海燕,孙一丹,曲辉.川崎病合并冠状动脉损害的治疗进展[J].中国医师进修杂志,2021,44(7):665-669. 被引量:10
-
4王亚洲,张笃飞,李一凡.阿司匹林不同减量方案的预测指标及在川崎病患儿治疗中的应用[J].岭南心血管病杂志,2023,29(2):162-166.
-
5吴迪,程婷,唐芳,罗顺清,曾衡,高樱,龙春莉.家庭管理干预对川崎病冠状动脉病变患儿父母疾病管理能力及家庭功能的影响[J].中国实用护理杂志,2023,39(16):1217-1223. 被引量:4
-
1路世红.华法林抗凝治疗心房颤动167例的健康指导[J].中国误诊学杂志,2011,11(21):5217-5217.
-
2李晓娟,张骞云,吴坎金,张连勇,马洪霞.普通肝素与低分子肝素治疗非大面积肺栓塞的疗效对比[J].中医学报,2014,29(B07):207-207.
-
3徐华清.美托洛尔联合稳心颗粒治疗心房颤动50例[J].现代预防医学,2012,39(3):783-783. 被引量:4
-
4殷红祥.探讨对房颤患者抗栓治疗的效果[J].中国实用医药,2014,9(29):141-142. 被引量:1
-
5杨东明,苏雪梅.2型糖尿病血脂水平与缺血性脑卒中的相关性研究[J].吉林医学,2009,30(15):1687-1688. 被引量:1
-
6郝增光,郑晓晖,王彦方,李现立.依那普利联合胺碘酮治疗阵发性房颤的临床观察[J].临床医学,2008,28(9):18-19. 被引量:3
-
7沙尼亚.吐尔孙.华法林抗凝治疗心房颤动临床疗效分析[J].中国伤残医学,2013,21(9):211-211. 被引量:1
-
8侯秀昌.华法林治疗心房颤动的疗效观察[J].中外医疗,2011,30(22):127-127. 被引量:7
-
9李敏.华法林治疗房颤临床观察[J].临床合理用药杂志,2013,6(5):31-31. 被引量:7
-
10顾卫霞.卡托普利对急性心肌梗死合并心房颤动患者的疗效观察[J].中华心血管病杂志,2005,33(9):809-809. 被引量:11